Tenet Healthcare price target raised to $105 from $70 at Barclays

Barclays raised the firm’s price target on Tenet Healthcare to $105 from $70 and keeps an Overweight rating on the shares. The analyst increased estimates to reflect the strength in underlying industry trends and the early momentum demonstrated by Tenet’s Q1 results. The company’s improved outlook for 2023 is based on strong hospital adjusted admissions growth and improved nurse staffing trends, the analyst tells investors in a research note.